Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Securities Class Action

Securities fraud litigation history and active cases

In Litigation

0

Settlement

0

Closed

1

Total Settlement

$1.26M

Cocrystal Pharma, Inc. (COCP) Class Action Lawsuit (September 2018)

Closed

2:18cv14091 • September 20, 2018

Class Period Start

September 23, 2013

Class Period End

December 7, 2018

PSLRA Deadline

November 19, 2018

Case Allegations

10b5

Statutes of Repose

Sep 23, 2016

Country

United States

Court

Federal Court

Settlement Information

Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.

Claim Deadline

November 16, 2020

Settlement Fund

$1,265,000

Settlement Status

Disbursed

Settlement Class

All persons or entities that purchased or otherwise acquired the publicly-traded securities of Cocrystal Pharma, Inc. (“Cocrystal”) and/or BioZone Pharmaceuticals, Inc. (“BioZone”) during the period between September 23, 2013 and September 7, 2018, both dates inclusive

Claim Administrator

Strategic Claims Services
Cocrystal Pharma, Inc. Securities Litigation c/o Strategic Claims Services 600 N. Jackson St., Ste. 205 P.O. Box 230 Media, PA 19063
+1 866-274-4004
[email protected]

Hearing Date

December 16, 2020

Opt-out Deadline

November 25, 2020

Settlement Note

Download here

Proof Of Claim

Download here

Docket History

Sep 1, 2021

Disbursement Approved

The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.

Dec 16, 2020

Final Approval of Settlement

The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.

Aug 18, 2020

Preliminary Approval of Settlement

The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.

Aug 18, 2020

Proof of Claim Form

To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.

May 26, 2020

Scheduling Order

View all Updates

TOP